跳至主要内容
临床试验/CTRI/2024/03/063534
CTRI/2024/03/063534尚未招募4 期

A Comparative study on efficacy and safety of N-Acetyl Cysteine as an add on therapy with standard therapy in patients with Rheumatoid arthritis- A Randomised Open Labelled Prospective study. - NI

Government Kilpauk Medical College0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Newly diagnosed as rheumatoid arthritis within 2 years by ACR criteria and having DAS 28-ESR score more than 3.2 who are not responding to standard therapy

排除标准

  • Newly diagnosed Rheumatoid arthritis patients having DAS 28-ESR score less than 3.2
  • History of Psychiatric illness or drug abuse
  • History of seizure disorder.
  • Known case of hypersensitive to N acetyl cysteine.
  • Pregnant and lactating females
  • History of any autoimmune disease other than rheumatoid arthritis
  • Patient taken biological agent therapy in last 6 months
  • Patients taking N acetyl cysteine for any other cause.

研究者

发起方
Government Kilpauk Medical College

相似试验